Rank | Gene Set | Z-score |
---|---|---|
1 | detection of molecule of bacterial origin (GO:0032490) | 6.63390211 |
2 | microglial cell activation (GO:0001774) | 5.68491285 |
3 | detection of external biotic stimulus (GO:0098581) | 5.14129176 |
4 | detection of other organism (GO:0098543) | 4.88848648 |
5 | macrophage activation (GO:0042116) | 4.78960610 |
6 | surfactant homeostasis (GO:0043129) | 4.74053166 |
7 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.73962498 |
8 | response to host immune response (GO:0052572) | 4.64986946 |
9 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.64986946 |
10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.61178763 |
11 | detection of biotic stimulus (GO:0009595) | 4.48940913 |
12 | neutrophil mediated immunity (GO:0002446) | 4.47746012 |
13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.39252427 |
14 | response to peptidoglycan (GO:0032494) | 4.29463692 |
15 | response to host (GO:0075136) | 4.29327432 |
16 | response to host defenses (GO:0052200) | 4.29327432 |
17 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.29327432 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.29155887 |
19 | negative regulation of interleukin-12 production (GO:0032695) | 4.27103411 |
20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.15453472 |
21 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.13465936 |
22 | detection of bacterium (GO:0016045) | 4.08692381 |
23 | myeloid leukocyte mediated immunity (GO:0002444) | 3.97430634 |
24 | chemical homeostasis within a tissue (GO:0048875) | 3.93379644 |
25 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.92471145 |
26 | B cell receptor signaling pathway (GO:0050853) | 3.88143889 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.86702883 |
28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83078946 |
29 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.81987747 |
30 | negative regulation of T cell mediated immunity (GO:0002710) | 3.76709799 |
31 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.75529659 |
32 | myeloid cell activation involved in immune response (GO:0002275) | 3.71611014 |
33 | positive regulation of Rap GTPase activity (GO:0032854) | 3.58403600 |
34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58185750 |
35 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.49400162 |
36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.47855592 |
37 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.38617394 |
38 | regulation of Rap GTPase activity (GO:0032317) | 3.37439163 |
39 | negative T cell selection (GO:0043383) | 3.34320583 |
40 | positive regulation of macrophage cytokine production (GO:0060907) | 3.31678246 |
41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26817734 |
42 | immunoglobulin mediated immune response (GO:0016064) | 3.23855609 |
43 | negative regulation of B cell mediated immunity (GO:0002713) | 3.18658580 |
44 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.18658580 |
45 | hepatocyte apoptotic process (GO:0097284) | 3.17900348 |
46 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.17124539 |
47 | negative regulation of B cell proliferation (GO:0030889) | 3.16229614 |
48 | T-helper 1 type immune response (GO:0042088) | 3.14071887 |
49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.13309659 |
50 | positive regulation of mast cell activation (GO:0033005) | 3.13156152 |
51 | defense response to protozoan (GO:0042832) | 3.13110086 |
52 | positive T cell selection (GO:0043368) | 3.12597965 |
53 | dendritic cell migration (GO:0036336) | 3.11486171 |
54 | regulation of interferon-alpha production (GO:0032647) | 3.06952030 |
55 | regulation of mast cell degranulation (GO:0043304) | 3.04756785 |
56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04094762 |
57 | type I interferon signaling pathway (GO:0060337) | 2.97273567 |
58 | cellular response to type I interferon (GO:0071357) | 2.97273567 |
59 | protein localization to endosome (GO:0036010) | 2.97021055 |
60 | cellular response to zinc ion (GO:0071294) | 2.96910484 |
61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96844591 |
62 | response to type I interferon (GO:0034340) | 2.96025196 |
63 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.95225130 |
64 | regulation of necroptotic process (GO:0060544) | 2.94211082 |
65 | myeloid leukocyte activation (GO:0002274) | 2.93306620 |
66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93275010 |
67 | negative regulation of adaptive immune response (GO:0002820) | 2.92863656 |
68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92771947 |
69 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.91506977 |
70 | regulation of mast cell activation (GO:0033003) | 2.90406402 |
71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90276517 |
72 | regulation of tolerance induction (GO:0002643) | 2.89484814 |
73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89228657 |
74 | activated T cell proliferation (GO:0050798) | 2.88973877 |
75 | response to muramyl dipeptide (GO:0032495) | 2.88449863 |
76 | positive regulation of B cell differentiation (GO:0045579) | 2.87044522 |
77 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84413677 |
78 | positive regulation of interferon-beta production (GO:0032728) | 2.81974716 |
79 | regulation of macrophage cytokine production (GO:0010935) | 2.74926635 |
80 | stress fiber assembly (GO:0043149) | 2.71511046 |
81 | regulation of ARF protein signal transduction (GO:0032012) | 2.64706825 |
82 | negative regulation of cell killing (GO:0031342) | 2.63071401 |
83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63071401 |
84 | cell adhesion mediated by integrin (GO:0033627) | 2.54638546 |
85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.52271408 |
86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.50763677 |
87 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.49470305 |
88 | regulation of synapse structural plasticity (GO:0051823) | 2.47793164 |
89 | regulation of B cell differentiation (GO:0045577) | 2.45312357 |
90 | prepulse inhibition (GO:0060134) | 2.44095316 |
91 | B cell proliferation (GO:0042100) | 2.43642861 |
92 | apoptotic cell clearance (GO:0043277) | 2.42441359 |
93 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.40857426 |
94 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.40294046 |
95 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.40064811 |
96 | macrophage activation involved in immune response (GO:0002281) | 2.38843676 |
97 | growth hormone receptor signaling pathway (GO:0060396) | 2.36262716 |
98 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.34307661 |
99 | mature B cell differentiation (GO:0002335) | 2.33773770 |
100 | response to interleukin-15 (GO:0070672) | 2.32918191 |
101 | cortical actin cytoskeleton organization (GO:0030866) | 2.30243928 |
102 | synaptic vesicle maturation (GO:0016188) | 2.29455915 |
103 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.28538806 |
104 | nerve growth factor signaling pathway (GO:0038180) | 2.28390005 |
105 | neutrophil activation (GO:0042119) | 2.28070524 |
106 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.27148467 |
107 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.27148467 |
108 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.27148467 |
109 | vocalization behavior (GO:0071625) | 2.26685550 |
110 | phosphate ion transmembrane transport (GO:0035435) | 2.26313926 |
111 | cellular extravasation (GO:0045123) | 2.25714361 |
112 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.25669627 |
113 | glomerular visceral epithelial cell development (GO:0072015) | 2.24515399 |
114 | phosphate ion transport (GO:0006817) | 2.24248258 |
115 | germinal center formation (GO:0002467) | 2.23337691 |
116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.21907734 |
117 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.21239126 |
118 | positive thymic T cell selection (GO:0045059) | 2.20642735 |
119 | substrate-dependent cell migration (GO:0006929) | 2.20461266 |
120 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.18837204 |
121 | establishment of nucleus localization (GO:0040023) | 2.18756596 |
122 | activation of protein kinase A activity (GO:0034199) | 2.18364932 |
123 | regulation of beta-amyloid formation (GO:1902003) | 2.18200499 |
124 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.18006260 |
125 | activation of JUN kinase activity (GO:0007257) | 2.17700114 |
126 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.16867470 |
127 | adenosine receptor signaling pathway (GO:0001973) | 2.16808099 |
128 | I-kappaB phosphorylation (GO:0007252) | 2.16494599 |
129 | cellular potassium ion homeostasis (GO:0030007) | 2.16175719 |
130 | potassium ion import (GO:0010107) | 2.15772509 |
131 | neutrophil activation involved in immune response (GO:0002283) | 2.15292725 |
132 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.14300941 |
133 | sodium ion export (GO:0071436) | 2.14270297 |
134 | granulocyte activation (GO:0036230) | 2.13799580 |
135 | negative regulation of vascular permeability (GO:0043116) | 2.13681823 |
136 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.13104469 |
137 | modulation by symbiont of host immune response (GO:0052553) | 2.13104469 |
138 | positive regulation by symbiont of host defense response (GO:0052509) | 2.13104469 |
139 | modulation by symbiont of host defense response (GO:0052031) | 2.13104469 |
140 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.13104469 |
141 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.13104469 |
142 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.12753458 |
143 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.12605479 |
144 | negative thymic T cell selection (GO:0045060) | 2.12558858 |
145 | positive regulation of interferon-alpha production (GO:0032727) | 2.11814676 |
146 | * locomotory exploration behavior (GO:0035641) | 2.11119069 |
147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.09916397 |
148 | cortical cytoskeleton organization (GO:0030865) | 2.08501002 |
149 | positive regulation of fibroblast migration (GO:0010763) | 2.08461870 |
150 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.08284194 |
151 | cellular response to interleukin-15 (GO:0071350) | 2.07580430 |
152 | establishment of endothelial barrier (GO:0061028) | 2.07395474 |
153 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.06403423 |
154 | regulation of leukocyte degranulation (GO:0043300) | 2.05659460 |
155 | leukocyte aggregation (GO:0070486) | 2.05643929 |
156 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.05442708 |
157 | plasma membrane repair (GO:0001778) | 2.05199044 |
158 | respiratory burst (GO:0045730) | 2.04853596 |
159 | regulation of regulated secretory pathway (GO:1903305) | 2.04714284 |
160 | negative regulation of fatty acid transport (GO:2000192) | 2.04387503 |
161 | hypotonic response (GO:0006971) | 2.04211141 |
162 | cAMP catabolic process (GO:0006198) | 2.04075929 |
163 | glomerular epithelial cell development (GO:0072310) | 2.03879421 |
164 | cAMP biosynthetic process (GO:0006171) | 2.01773198 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.28898309 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.19584398 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.62617159 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43314199 |
5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40748628 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.36753935 |
7 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.36439215 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.31920045 |
9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10621617 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08835905 |
11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98554407 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93228580 |
13 | MYB_26560356_Chip-Seq_TH1_Human | 1.86656333 |
14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84120025 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80780470 |
16 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.75947737 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73724632 |
18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73234190 |
19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70888771 |
20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70500276 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70375114 |
22 | MAF_26560356_Chip-Seq_TH1_Human | 1.68216542 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67430587 |
24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66305841 |
25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64427092 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62088431 |
27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61772149 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61648408 |
29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60065567 |
30 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57722476 |
31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57604559 |
32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56089842 |
33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55617033 |
34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55459540 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51968549 |
36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50955193 |
37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49646343 |
38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49592920 |
39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.48945937 |
40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48040454 |
41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47864040 |
42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47668273 |
43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44416332 |
44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.43958004 |
45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43256755 |
46 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.42395972 |
47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41750847 |
48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40984724 |
49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39760710 |
50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39276604 |
51 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38547501 |
52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38527113 |
53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38250516 |
54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38217254 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38030037 |
56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37266032 |
57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36968071 |
58 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35325189 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35030670 |
60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33955567 |
61 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.33153997 |
62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32670028 |
63 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32655349 |
64 | RXR_22108803_ChIP-Seq_LS180_Human | 1.32573378 |
65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29493259 |
66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29236080 |
67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29236080 |
68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26593056 |
69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25432848 |
70 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.23607585 |
71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23173394 |
72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22900572 |
73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22095671 |
74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21279657 |
75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20905129 |
76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19933100 |
77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19826623 |
78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19319638 |
79 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19100307 |
80 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18683670 |
81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18475205 |
82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18078844 |
83 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17906682 |
84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.17731737 |
85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17212000 |
86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16147415 |
87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15572019 |
88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15411681 |
89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14383840 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13978199 |
91 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13669416 |
92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11877441 |
93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11111000 |
94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10872913 |
95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10872913 |
96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10498775 |
97 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10288711 |
98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08911681 |
99 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08842749 |
100 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06868669 |
101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04792081 |
102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04079833 |
103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02656552 |
104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.02051905 |
105 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01167882 |
106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00652860 |
107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00092522 |
108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97605491 |
109 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.97490019 |
110 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97300606 |
111 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96690142 |
112 | MAF_26560356_Chip-Seq_TH2_Human | 0.96574976 |
113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96201813 |
114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95590928 |
115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95195871 |
116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94210459 |
117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94091420 |
118 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94025707 |
119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93478928 |
120 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92679444 |
121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92335942 |
122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91915019 |
123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91754337 |
124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91494039 |
125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89829499 |
126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89702974 |
127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89588636 |
128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89586976 |
129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89586976 |
130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89045701 |
131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88850515 |
132 | MYB_26560356_Chip-Seq_TH2_Human | 0.88838926 |
133 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88567476 |
134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88490743 |
135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88318321 |
136 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88100166 |
137 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87665281 |
138 | MYC_22102868_ChIP-Seq_BL_Human | 0.86501773 |
139 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86359192 |
140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83735544 |
141 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82238673 |
142 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80956434 |
143 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73388442 |
144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72782387 |
145 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71873608 |
146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69937902 |
147 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.69631852 |
148 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.69245142 |
149 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66149185 |
150 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65505664 |
151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65300590 |
152 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64728019 |
153 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.64704034 |
154 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.64339118 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001958_emphysema | 4.00055264 |
2 | MP0003303_peritoneal_inflammation | 3.37213789 |
3 | MP0000569_abnormal_digit_pigmentation | 3.30764007 |
4 | MP0001835_abnormal_antigen_presentation | 3.14198695 |
5 | MP0001790_abnormal_immune_system | 2.87732596 |
6 | MP0005387_immune_system_phenotype | 2.87732596 |
7 | MP0004859_abnormal_synaptic_plasticity | 2.82938798 |
8 | MP0003300_gastrointestinal_ulcer | 2.54504054 |
9 | MP0005451_abnormal_body_composition | 2.46494497 |
10 | MP0002822_catalepsy | 2.41480025 |
11 | MP0004381_abnormal_hair_follicle | 2.23909848 |
12 | MP0003091_abnormal_cell_migration | 2.19634127 |
13 | MP0004510_myositis | 2.16091916 |
14 | MP0001800_abnormal_humoral_immune | 2.13996629 |
15 | MP0006082_CNS_inflammation | 2.13021143 |
16 | MP0000685_abnormal_immune_system | 2.04557072 |
17 | MP0005167_abnormal_blood-brain_barrier | 2.00274293 |
18 | MP0003045_fibrosis | 2.00218687 |
19 | MP0003763_abnormal_thymus_physiology | 1.99336243 |
20 | MP0003183_abnormal_peptide_metabolism | 1.98792702 |
21 | MP0004782_abnormal_surfactant_physiolog | 1.94965328 |
22 | MP0005000_abnormal_immune_tolerance | 1.91555073 |
23 | MP0003787_abnormal_imprinting | 1.89952885 |
24 | MP0002452_abnormal_antigen_presenting | 1.88319872 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.85191712 |
26 | MP0010234_abnormal_vibrissa_follicle | 1.82930622 |
27 | MP0010352_gastrointestinal_tract_polyps | 1.77064927 |
28 | * MP0008260_abnormal_autophagy | 1.74084925 |
29 | MP0003436_decreased_susceptibility_to | 1.72541968 |
30 | MP0002132_abnormal_respiratory_system | 1.70398183 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 1.68592021 |
32 | MP0003279_aneurysm | 1.64987831 |
33 | MP0008438_abnormal_cutaneous_collagen | 1.63898291 |
34 | MP0003566_abnormal_cell_adhesion | 1.63123782 |
35 | MP0003075_altered_response_to | 1.59837567 |
36 | MP0001177_atelectasis | 1.59163004 |
37 | MP0002133_abnormal_respiratory_system | 1.58985023 |
38 | MP0005388_respiratory_system_phenotype | 1.58985023 |
39 | MP0008961_abnormal_basal_metabolism | 1.56543617 |
40 | MP0000015_abnormal_ear_pigmentation | 1.55146852 |
41 | MP0002419_abnormal_innate_immunity | 1.54442880 |
42 | MP0003690_abnormal_glial_cell | 1.51178303 |
43 | MP0002722_abnormal_immune_system | 1.47339859 |
44 | MP0002723_abnormal_immune_serum | 1.45260770 |
45 | MP0005623_abnormal_meninges_morphology | 1.45026761 |
46 | MP0003866_abnormal_defecation | 1.44735294 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.43652639 |
48 | MP0002166_altered_tumor_susceptibility | 1.43588192 |
49 | MP0002420_abnormal_adaptive_immunity | 1.43543837 |
50 | MP0000858_altered_metastatic_potential | 1.42684128 |
51 | MP0003635_abnormal_synaptic_transmissio | 1.42516899 |
52 | MP0001819_abnormal_immune_cell | 1.39849144 |
53 | MP0005058_abnormal_lysosome_morphology | 1.39847207 |
54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37679043 |
55 | MP0003705_abnormal_hypodermis_morpholog | 1.36549480 |
56 | MP0002277_abnormal_respiratory_mucosa | 1.35488247 |
57 | MP0009780_abnormal_chondrocyte_physiolo | 1.34688330 |
58 | MP0002168_other_aberrant_phenotype | 1.34148173 |
59 | MP0002396_abnormal_hematopoietic_system | 1.32811692 |
60 | MP0000703_abnormal_thymus_morphology | 1.31843792 |
61 | * MP0002429_abnormal_blood_cell | 1.31534972 |
62 | MP0001879_abnormal_lymphatic_vessel | 1.31194016 |
63 | MP0005397_hematopoietic_system_phenotyp | 1.31089892 |
64 | MP0001545_abnormal_hematopoietic_system | 1.31089892 |
65 | MP0005174_abnormal_tail_pigmentation | 1.30001060 |
66 | MP0001851_eye_inflammation | 1.29218085 |
67 | MP0005166_decreased_susceptibility_to | 1.28538045 |
68 | MP0008004_abnormal_stomach_pH | 1.27817555 |
69 | MP0005075_abnormal_melanosome_morpholog | 1.26574214 |
70 | MP0009278_abnormal_bone_marrow | 1.25845102 |
71 | MP0002006_tumorigenesis | 1.22153898 |
72 | MP0002295_abnormal_pulmonary_circulatio | 1.21179577 |
73 | MP0009046_muscle_twitch | 1.20631465 |
74 | MP0002148_abnormal_hypersensitivity_rea | 1.19774353 |
75 | MP0008469_abnormal_protein_level | 1.18191309 |
76 | MP0009785_altered_susceptibility_to | 1.14951982 |
77 | * MP0009745_abnormal_behavioral_response | 1.13889344 |
78 | MP0005025_abnormal_response_to | 1.13339262 |
79 | MP0002063_abnormal_learning/memory/cond | 1.12441143 |
80 | * MP0002136_abnormal_kidney_physiology | 1.12008022 |
81 | MP0002332_abnormal_exercise_endurance | 1.10395551 |
82 | MP0002405_respiratory_system_inflammati | 1.10167140 |
83 | MP0005671_abnormal_response_to | 1.08370967 |
84 | MP0002928_abnormal_bile_duct | 1.07346582 |
85 | MP0001765_abnormal_ion_homeostasis | 1.06470027 |
86 | MP0003172_abnormal_lysosome_physiology | 1.05917253 |
87 | MP0003724_increased_susceptibility_to | 1.03852987 |
88 | MP0003828_pulmonary_edema | 1.03589382 |
89 | MP0005464_abnormal_platelet_physiology | 1.02235800 |
90 | MP0001873_stomach_inflammation | 1.01891260 |
91 | MP0004808_abnormal_hematopoietic_stem | 1.01461232 |
92 | * MP0000716_abnormal_immune_system | 1.01291435 |
93 | MP0008057_abnormal_DNA_replication | 1.00973972 |
94 | * MP0008874_decreased_physiological_sensi | 1.00876871 |
95 | MP0004883_abnormal_blood_vessel | 0.99168547 |
96 | MP0002064_seizures | 0.98737591 |
97 | MP0004947_skin_inflammation | 0.98432372 |
98 | MP0009764_decreased_sensitivity_to | 0.98094756 |
99 | * MP0001845_abnormal_inflammatory_respons | 0.97224430 |
100 | MP0000767_abnormal_smooth_muscle | 0.97140718 |
101 | MP0004484_altered_response_of | 0.94887503 |
102 | MP0000343_altered_response_to | 0.94652341 |
103 | MP0009333_abnormal_splenocyte_physiolog | 0.93074466 |
104 | MP0002998_abnormal_bone_remodeling | 0.92861535 |
105 | MP0002398_abnormal_bone_marrow | 0.92712310 |
106 | MP0001853_heart_inflammation | 0.92380600 |
107 | MP0003191_abnormal_cellular_cholesterol | 0.91667386 |
108 | MP0005310_abnormal_salivary_gland | 0.91086632 |
109 | MP0000604_amyloidosis | 0.90833812 |
110 | MP0001533_abnormal_skeleton_physiology | 0.90673869 |
111 | MP0001501_abnormal_sleep_pattern | 0.89091923 |
112 | MP0010368_abnormal_lymphatic_system | 0.89022802 |
113 | MP0000249_abnormal_blood_vessel | 0.88129715 |
114 | MP0005164_abnormal_response_to | 0.85013621 |
115 | MP0003329_amyloid_beta_deposits | 0.82887784 |
116 | MP0004272_abnormal_basement_membrane | 0.82066557 |
117 | MP0005023_abnormal_wound_healing | 0.81769748 |
118 | MP0000689_abnormal_spleen_morphology | 0.81572341 |
119 | MP0005275_abnormal_skin_tensile | 0.81165927 |
120 | MP0003633_abnormal_nervous_system | 0.81109146 |
121 | MP0001968_abnormal_touch/_nociception | 0.80559229 |
122 | MP0001756_abnormal_urination | 0.80384854 |
123 | MP0000013_abnormal_adipose_tissue | 0.80015935 |
124 | MP0008569_lethality_at_weaning | 0.79720354 |
125 | MP0003448_altered_tumor_morphology | 0.79331964 |
126 | MP0010155_abnormal_intestine_physiology | 0.78101554 |
127 | MP0004858_abnormal_nervous_system | 0.77409950 |
128 | MP0008877_abnormal_DNA_methylation | 0.77272042 |
129 | MP0009763_increased_sensitivity_to | 0.77203326 |
130 | MP0004130_abnormal_muscle_cell | 0.77128972 |
131 | MP0000371_diluted_coat_color | 0.76006968 |
132 | MP0002009_preneoplasia | 0.74073661 |
133 | MP0005376_homeostasis/metabolism_phenot | 0.74073117 |
134 | MP0006054_spinal_hemorrhage | 0.69837014 |
135 | MP0009765_abnormal_xenobiotic_induced | 0.63740824 |
136 | MP0001663_abnormal_digestive_system | 0.61094773 |
137 | MP0005390_skeleton_phenotype | 0.56104086 |
138 | MP0003252_abnormal_bile_duct | 0.53761696 |
139 | MP0005408_hypopigmentation | 0.52035668 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Retrobulbar optic neuritis (HP:0100654) | 5.64984859 |
2 | Optic neuritis (HP:0100653) | 5.64984859 |
3 | Orchitis (HP:0100796) | 5.62854692 |
4 | Myositis (HP:0100614) | 5.53213482 |
5 | Interstitial pulmonary disease (HP:0006530) | 4.86666476 |
6 | Gastrointestinal infarctions (HP:0005244) | 4.79198746 |
7 | T lymphocytopenia (HP:0005403) | 4.42913036 |
8 | Keratoconjunctivitis sicca (HP:0001097) | 4.28304467 |
9 | Abnormality of T cell number (HP:0011839) | 4.21631517 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99742503 |
11 | Peritonitis (HP:0002586) | 3.99092923 |
12 | Keratoconjunctivitis (HP:0001096) | 3.93484368 |
13 | Gastrointestinal stroma tumor (HP:0100723) | 3.91716071 |
14 | Stomatitis (HP:0010280) | 3.89293262 |
15 | Agammaglobulinemia (HP:0004432) | 3.82432631 |
16 | Gingival bleeding (HP:0000225) | 3.64554229 |
17 | Hematochezia (HP:0002573) | 3.59616056 |
18 | Arterial thrombosis (HP:0004420) | 3.56970688 |
19 | Colitis (HP:0002583) | 3.56088035 |
20 | Encephalitis (HP:0002383) | 3.45862428 |
21 | Cellulitis (HP:0100658) | 3.45301876 |
22 | Obstructive lung disease (HP:0006536) | 3.39394234 |
23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39394234 |
24 | Recurrent abscess formation (HP:0002722) | 3.38239339 |
25 | Eczematoid dermatitis (HP:0000976) | 3.28844181 |
26 | Cerebral aneurysm (HP:0004944) | 3.26970014 |
27 | Chest pain (HP:0100749) | 3.26181736 |
28 | Hemoptysis (HP:0002105) | 3.23202869 |
29 | Hyperactive renin-angiotensin system (HP:0000841) | 3.21474065 |
30 | Urticaria (HP:0001025) | 3.13325189 |
31 | Recurrent bacterial skin infections (HP:0005406) | 3.12667446 |
32 | Mitral stenosis (HP:0001718) | 3.06404658 |
33 | Leukocytosis (HP:0001974) | 3.02483537 |
34 | Abnormality of T cells (HP:0002843) | 2.85574009 |
35 | Emphysema (HP:0002097) | 2.82363083 |
36 | Pulmonary embolism (HP:0002204) | 2.80603769 |
37 | Inflammation of the large intestine (HP:0002037) | 2.80596674 |
38 | Absent frontal sinuses (HP:0002688) | 2.77160739 |
39 | Epistaxis (HP:0000421) | 2.72011485 |
40 | Hypokalemic alkalosis (HP:0001949) | 2.68247922 |
41 | Anorexia (HP:0002039) | 2.66168798 |
42 | Verrucae (HP:0200043) | 2.65455835 |
43 | Papilloma (HP:0012740) | 2.65455835 |
44 | Prolonged bleeding time (HP:0003010) | 2.65046357 |
45 | Gastrointestinal inflammation (HP:0004386) | 2.63705219 |
46 | Restrictive lung disease (HP:0002091) | 2.61118044 |
47 | Abnormality of the peritoneum (HP:0002585) | 2.58624265 |
48 | Ulnar bowing (HP:0003031) | 2.58255692 |
49 | Gangrene (HP:0100758) | 2.57718447 |
50 | Mediastinal lymphadenopathy (HP:0100721) | 2.57642114 |
51 | Episodic fever (HP:0001954) | 2.57308830 |
52 | Amyloidosis (HP:0011034) | 2.53595583 |
53 | Papilledema (HP:0001085) | 2.53261633 |
54 | Slow saccadic eye movements (HP:0000514) | 2.51460001 |
55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51123031 |
56 | * Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.45158138 |
57 | Vertebral arch anomaly (HP:0008438) | 2.43573921 |
58 | Gout (HP:0001997) | 2.40537681 |
59 | Abnormality of chloride homeostasis (HP:0011422) | 2.39515225 |
60 | Increased IgE level (HP:0003212) | 2.39215466 |
61 | Eosinophilia (HP:0001880) | 2.38318503 |
62 | Metabolic alkalosis (HP:0200114) | 2.38256599 |
63 | Recurrent bronchitis (HP:0002837) | 2.37724580 |
64 | Aortic aneurysm (HP:0004942) | 2.36598074 |
65 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35484957 |
66 | Osteolytic defects of the hand bones (HP:0009699) | 2.35484957 |
67 | Increased circulating renin level (HP:0000848) | 2.34587640 |
68 | Granulocytopenia (HP:0001913) | 2.33062422 |
69 | Abnormality of the endocardium (HP:0004306) | 2.33025231 |
70 | Osteomyelitis (HP:0002754) | 2.30886942 |
71 | Dilatation of the ascending aorta (HP:0005111) | 2.30536068 |
72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29714639 |
73 | Acute hepatic failure (HP:0006554) | 2.27593845 |
74 | Focal motor seizures (HP:0011153) | 2.23750864 |
75 | Viral hepatitis (HP:0006562) | 2.22504758 |
76 | Abnormality of the pleura (HP:0002103) | 2.22503817 |
77 | Hypochromic microcytic anemia (HP:0004840) | 2.20759048 |
78 | Chronic otitis media (HP:0000389) | 2.19259854 |
79 | Recurrent fungal infections (HP:0002841) | 2.19076193 |
80 | Focal seizures (HP:0007359) | 2.17340384 |
81 | Recurrent viral infections (HP:0004429) | 2.17286115 |
82 | Spontaneous hematomas (HP:0007420) | 2.17220110 |
83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16685892 |
84 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16685892 |
85 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.13070066 |
86 | Abnormality of macrophages (HP:0004311) | 2.12414505 |
87 | Recurrent skin infections (HP:0001581) | 2.11326493 |
88 | Vertigo (HP:0002321) | 2.10105879 |
89 | Sepsis (HP:0100806) | 2.09561924 |
90 | Vasculitis (HP:0002633) | 2.09488217 |
91 | IgA deficiency (HP:0002720) | 2.08895765 |
92 | Glomerulopathy (HP:0100820) | 2.07667551 |
93 | Lymphopenia (HP:0001888) | 2.07612633 |
94 | Hypochromic anemia (HP:0001931) | 2.07014992 |
95 | Keratitis (HP:0000491) | 2.06430983 |
96 | Gingivitis (HP:0000230) | 2.05194235 |
97 | Renal salt wasting (HP:0000127) | 2.02245200 |
98 | Recurrent sinusitis (HP:0011108) | 2.01937711 |
99 | Broad metatarsal (HP:0001783) | 2.01531442 |
100 | Abnormality of the fingertips (HP:0001211) | 2.01509579 |
101 | Abnormality of eosinophils (HP:0001879) | 2.00592496 |
102 | Thrombophlebitis (HP:0004418) | 2.00503904 |
103 | Microcytic anemia (HP:0001935) | 1.98100664 |
104 | Autoimmune thrombocytopenia (HP:0001973) | 1.95975944 |
105 | Tubulointerstitial fibrosis (HP:0005576) | 1.95278404 |
106 | Pustule (HP:0200039) | 1.95206415 |
107 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94542102 |
108 | Mitral valve prolapse (HP:0001634) | 1.93114693 |
109 | Dysmetric saccades (HP:0000641) | 1.92890770 |
110 | Acne (HP:0001061) | 1.92362953 |
111 | Camptodactyly of toe (HP:0001836) | 1.91667408 |
112 | Arterial tortuosity (HP:0005116) | 1.91321088 |
113 | Action tremor (HP:0002345) | 1.90905003 |
114 | Cheilitis (HP:0100825) | 1.89816731 |
115 | Difficulty running (HP:0009046) | 1.89786649 |
116 | Aqueductal stenosis (HP:0002410) | 1.88917633 |
117 | Shallow orbits (HP:0000586) | 1.88619207 |
118 | Myokymia (HP:0002411) | 1.88274421 |
119 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88145103 |
120 | Long toe (HP:0010511) | 1.88046422 |
121 | Autoimmune hemolytic anemia (HP:0001890) | 1.87637960 |
122 | Increased IgM level (HP:0003496) | 1.87599688 |
123 | Vascular tortuosity (HP:0004948) | 1.87377106 |
124 | Chronic sinusitis (HP:0011109) | 1.86212466 |
125 | IgM deficiency (HP:0002850) | 1.86020658 |
126 | Abnormality of renal excretion (HP:0011036) | 1.85789216 |
127 | Papillary thyroid carcinoma (HP:0002895) | 1.85697858 |
128 | Hemangiomatosis (HP:0007461) | 1.85564050 |
129 | Increased density of long bones (HP:0006392) | 1.85237157 |
130 | Macroorchidism (HP:0000053) | 1.85180355 |
131 | Hypomagnesemia (HP:0002917) | 1.84976942 |
132 | Skin ulcer (HP:0200042) | 1.84583427 |
133 | Persistence of primary teeth (HP:0006335) | 1.84354708 |
134 | Polycythemia (HP:0001901) | 1.84242100 |
135 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.83678904 |
136 | Abnormality of T cell physiology (HP:0011840) | 1.83370082 |
137 | Meningitis (HP:0001287) | 1.82953308 |
138 | Stomach cancer (HP:0012126) | 1.82432078 |
139 | Amaurosis fugax (HP:0100576) | 1.82393980 |
140 | Fatigue (HP:0012378) | 1.81736986 |
141 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81392996 |
142 | Pulmonary infiltrates (HP:0002113) | 1.81278059 |
143 | Visceral angiomatosis (HP:0100761) | 1.80445209 |
144 | Distal lower limb amyotrophy (HP:0008944) | 1.80230507 |
145 | Lower limb amyotrophy (HP:0007210) | 1.80056465 |
146 | Subacute progressive viral hepatitis (HP:0006572) | 1.79732698 |
147 | Alveolar cell carcinoma (HP:0006519) | 1.78720315 |
148 | Xerostomia (HP:0000217) | 1.78171194 |
149 | Polyuria (HP:0000103) | 1.77665196 |
150 | Upper limb amyotrophy (HP:0009129) | 1.77205066 |
151 | Distal upper limb amyotrophy (HP:0007149) | 1.77205066 |
152 | Atonic seizures (HP:0010819) | 1.75567884 |
153 | Hypergammaglobulinemia (HP:0010702) | 1.74610221 |
154 | Abnormal urine output (HP:0012590) | 1.74475875 |
155 | Hyperaldosteronism (HP:0000859) | 1.73880545 |
156 | Recurrent pneumonia (HP:0006532) | 1.73629639 |
157 | Periodontitis (HP:0000704) | 1.72824484 |
158 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.72626180 |
159 | Facial diplegia (HP:0001349) | 1.72210957 |
160 | Panhypogammaglobulinemia (HP:0003139) | 1.71654409 |
161 | Paresthesia (HP:0003401) | 1.71632520 |
162 | Tachypnea (HP:0002789) | 1.71501971 |
163 | Conjunctival telangiectasia (HP:0000524) | 1.71358074 |
164 | Hemiplegia (HP:0002301) | 1.70243533 |
165 | Syringomyelia (HP:0003396) | 1.69129387 |
166 | Spinal cord lesions (HP:0100561) | 1.69129387 |
167 | Tetany (HP:0001281) | 1.68806210 |
168 | Bowed forearm bones (HP:0003956) | 1.68221253 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.07270090 |
2 | IRAK4 | 3.15631440 |
3 | MAP3K13 | 3.01100278 |
4 | MAP2K3 | 2.82733848 |
5 | EPHA4 | 2.76683034 |
6 | MAP4K1 | 2.71427462 |
7 | MAP3K9 | 2.64765801 |
8 | TTN | 2.58486092 |
9 | RIPK1 | 1.97518867 |
10 | TRIB3 | 1.85086999 |
11 | MAP3K14 | 1.84560733 |
12 | JAK1 | 1.84039303 |
13 | IRAK1 | 1.83562645 |
14 | TXK | 1.81854808 |
15 | DAPK2 | 1.73833425 |
16 | SIK2 | 1.70190504 |
17 | GRK6 | 1.68691712 |
18 | TAOK3 | 1.65094531 |
19 | KSR2 | 1.58068587 |
20 | YES1 | 1.56460778 |
21 | JAK2 | 1.56457293 |
22 | IRAK2 | 1.54926779 |
23 | FES | 1.54877140 |
24 | CAMK1G | 1.52616934 |
25 | PIK3CG | 1.51383870 |
26 | CAMK1D | 1.45896703 |
27 | NTRK3 | 1.45442376 |
28 | SGK3 | 1.44887053 |
29 | PRPF4B | 1.43055846 |
30 | MAP3K1 | 1.39455983 |
31 | BMPR2 | 1.39287467 |
32 | CSF1R | 1.37394357 |
33 | MAP3K6 | 1.37026401 |
34 | CAMKK1 | 1.36492571 |
35 | WNK1 | 1.35168980 |
36 | PTK2B | 1.34198778 |
37 | MAP3K3 | 1.33206007 |
38 | PRKCH | 1.31470231 |
39 | FGFR3 | 1.30006208 |
40 | CSK | 1.28824657 |
41 | TYK2 | 1.27614185 |
42 | FRK | 1.27594483 |
43 | FGFR2 | 1.24849160 |
44 | ERN1 | 1.24844506 |
45 | OXSR1 | 1.24503102 |
46 | EPHB1 | 1.22645268 |
47 | STK10 | 1.21557570 |
48 | FGR | 1.20491647 |
49 | HCK | 1.20113448 |
50 | CAMKK2 | 1.14035419 |
51 | WNK4 | 1.12460880 |
52 | SYK | 1.11510002 |
53 | SGK2 | 1.11075196 |
54 | NTRK1 | 1.09391249 |
55 | TEC | 1.09040001 |
56 | TGFBR2 | 1.07489061 |
57 | PDK1 | 0.99935485 |
58 | BLK | 0.99226101 |
59 | MARK3 | 0.98716738 |
60 | LCK | 0.98343915 |
61 | PDGFRA | 0.97224008 |
62 | PDPK1 | 0.94733217 |
63 | NLK | 0.92911356 |
64 | EPHA3 | 0.92428045 |
65 | PTK6 | 0.91002581 |
66 | RAF1 | 0.88770891 |
67 | JAK3 | 0.87314604 |
68 | PRKCQ | 0.85866546 |
69 | MAP3K11 | 0.85690516 |
70 | STK11 | 0.85236615 |
71 | SGK494 | 0.85116434 |
72 | SGK223 | 0.85116434 |
73 | MAP2K4 | 0.84270754 |
74 | PDGFRB | 0.83973905 |
75 | GRK5 | 0.82013919 |
76 | DMPK | 0.81944290 |
77 | MAP3K2 | 0.81684586 |
78 | BTK | 0.80672671 |
79 | BMX | 0.78540327 |
80 | CDC42BPA | 0.77470933 |
81 | STK4 | 0.77341385 |
82 | MAP3K5 | 0.75786787 |
83 | FYN | 0.75592224 |
84 | MATK | 0.75417130 |
85 | WNK3 | 0.75149057 |
86 | DAPK1 | 0.74823650 |
87 | MAP3K7 | 0.74550965 |
88 | SGK1 | 0.73315554 |
89 | SIK1 | 0.73062504 |
90 | KSR1 | 0.71771591 |
91 | TBK1 | 0.70582899 |
92 | SIK3 | 0.68975022 |
93 | TAOK1 | 0.68318842 |
94 | TRPM7 | 0.68070115 |
95 | ALK | 0.67943889 |
96 | PIM1 | 0.66571684 |
97 | * LRRK2 | 0.66477616 |
98 | RET | 0.65355060 |
99 | DDR2 | 0.65283637 |
100 | MAP3K12 | 0.63892037 |
101 | ERBB2 | 0.63567161 |
102 | PAK6 | 0.62936473 |
103 | CDK5 | 0.62912921 |
104 | KIT | 0.61742483 |
105 | TNK2 | 0.61609709 |
106 | EGFR | 0.61138767 |
107 | GRK1 | 0.61105509 |
108 | ZAP70 | 0.58649664 |
109 | IKBKB | 0.58354502 |
110 | SCYL2 | 0.57402589 |
111 | LMTK2 | 0.57209981 |
112 | PRKD2 | 0.56963412 |
113 | INSR | 0.55358808 |
114 | DYRK1B | 0.55137253 |
115 | MINK1 | 0.54230069 |
116 | TIE1 | 0.54141374 |
117 | MAP3K10 | 0.52799241 |
118 | CDK19 | 0.52731778 |
119 | PRKD1 | 0.52640127 |
120 | LYN | 0.51926715 |
121 | MAP2K1 | 0.51913999 |
122 | MARK2 | 0.51449153 |
123 | ITK | 0.51376422 |
124 | IKBKE | 0.50878830 |
125 | FGFR4 | 0.50817309 |
126 | ACVR1B | 0.50724244 |
127 | PKN2 | 0.50461049 |
128 | DYRK1A | 0.49518468 |
129 | DYRK3 | 0.49433553 |
130 | IRAK3 | 0.48162894 |
131 | STK38 | 0.45446798 |
132 | NEK9 | 0.44318139 |
133 | MAPK7 | 0.42563393 |
134 | HIPK2 | 0.42206485 |
135 | MAPK12 | 0.42107682 |
136 | CAMK4 | 0.41169992 |
137 | MAP2K6 | 0.40983104 |
138 | PAK3 | 0.38749305 |
139 | NEK6 | 0.34752464 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58038023 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.47402303 |
3 | Measles_Homo sapiens_hsa05162 | 1.81171506 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73391443 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71351453 |
6 | Legionellosis_Homo sapiens_hsa05134 | 1.68138167 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 1.67893490 |
8 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.67751610 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61801354 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54652069 |
11 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.54002401 |
12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.53656907 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51107822 |
14 | Influenza A_Homo sapiens_hsa05164 | 1.50495165 |
15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49208349 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46680173 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45095092 |
18 | Salivary secretion_Homo sapiens_hsa04970 | 1.42039721 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41418173 |
20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38091093 |
21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33335888 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33188244 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.32696359 |
24 | Morphine addiction_Homo sapiens_hsa05032 | 1.32531192 |
25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29890922 |
26 | Hepatitis B_Homo sapiens_hsa05161 | 1.29737706 |
27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.28375909 |
28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28304285 |
29 | Glioma_Homo sapiens_hsa05214 | 1.24454378 |
30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24160580 |
31 | Platelet activation_Homo sapiens_hsa04611 | 1.23693483 |
32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21844050 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.20701079 |
34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19966485 |
35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.19158159 |
36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18368716 |
37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17291679 |
38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16910360 |
39 | Hepatitis C_Homo sapiens_hsa05160 | 1.15160162 |
40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14927035 |
41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.13641680 |
42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12310226 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10686812 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10377080 |
45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09770481 |
46 | Focal adhesion_Homo sapiens_hsa04510 | 1.07097244 |
47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06585783 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05881201 |
49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05453721 |
50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05392923 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05367743 |
52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04447401 |
53 | Apoptosis_Homo sapiens_hsa04210 | 1.04337668 |
54 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.04062893 |
55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03674185 |
56 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03640596 |
57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03284461 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02569761 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02105378 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02103627 |
61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98742351 |
62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98095712 |
63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97065293 |
64 | Salmonella infection_Homo sapiens_hsa05132 | 0.95602740 |
65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94923906 |
66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94885540 |
67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94643580 |
68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94525691 |
69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94057284 |
70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93652970 |
71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92889092 |
72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92694943 |
73 | Amoebiasis_Homo sapiens_hsa05146 | 0.92447368 |
74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92376871 |
75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92329223 |
76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92149705 |
77 | Shigellosis_Homo sapiens_hsa05131 | 0.91354773 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91042342 |
79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90904241 |
80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90152619 |
81 | Malaria_Homo sapiens_hsa05144 | 0.89981329 |
82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88931990 |
83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88679143 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88013316 |
85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87964631 |
86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87439287 |
87 | Gap junction_Homo sapiens_hsa04540 | 0.86344491 |
88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86181365 |
89 | Long-term depression_Homo sapiens_hsa04730 | 0.86137304 |
90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86050275 |
91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85679270 |
92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85384903 |
93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83779504 |
94 | Pertussis_Homo sapiens_hsa05133 | 0.83079360 |
95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82920316 |
96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82634606 |
97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81687031 |
98 | Phagosome_Homo sapiens_hsa04145 | 0.80530769 |
99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80200361 |
100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.79239152 |
101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78776285 |
102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78233793 |
103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77378352 |
104 | Asthma_Homo sapiens_hsa05310 | 0.75122478 |
105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75065903 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.74809724 |
107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73833847 |
108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73482661 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72802493 |
110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72625956 |
111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72234429 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.72214284 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72018503 |
114 | Adherens junction_Homo sapiens_hsa04520 | 0.70901213 |
115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69825188 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69379113 |
117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69307139 |
118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69002387 |
119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68549375 |
120 | Insulin secretion_Homo sapiens_hsa04911 | 0.67564299 |
121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67536308 |
122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67160386 |
123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64081404 |
124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63970126 |
125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62948647 |
126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62588385 |
127 | Insulin resistance_Homo sapiens_hsa04931 | 0.62509751 |
128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62279315 |
129 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62243307 |
130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61746521 |
131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60284680 |
132 | Prostate cancer_Homo sapiens_hsa05215 | 0.59460255 |
133 | Taste transduction_Homo sapiens_hsa04742 | 0.58801012 |
134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56361490 |
135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52623407 |
136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46067225 |
137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44566667 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43687538 |
139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43578040 |